... Studies at the 2018 San Antonio Breast Cancer Symposium Evaluating HER2-Negative Breast Cancer Tumors with ... “Celcuity Announces Clinical Trial Collaboration with Puma Biotechnology and West Cancer Center – Business ...
News
- EPS for Celcuity Inc. (CELC) Expected At $-0.22 on May, 13
- Anticipated $-0.22 EPS for Celcuity Inc. (CELC) on May, 13
... Stocks Year-to-Date – Investing News Network” published on December 04, 2018, “Biotech startup Celcuity raises ... San Antonio Breast Cancer Symposium Evaluating HER2-Negative Breast Cancer Tumors with Hyperactive and ...
- Plans for Chrysler site inching forward
The Waymaker Group LLC of San Antonio received a nine-month contract on April 1 at $22,500 per month. The project ... Biotechnology/life science.
- Texas Biomed VP to lead city's vaccine development group
The vaccine center is a collaboration of four research institutions — Texas Biomed, UT Health San Antonio, the University of Texas at San Antonio ...
- There's now a cure for the deadly genetic disorder known as 'bubble boy' disease
The new experimental treatment is called MB-107, and it's being developed by the biotech Mustang Bio, which has a market value of roughly $80 ...